FDA Inspection 1231137 — The American National Red Cross Diagnostic Manufacturing Division
The FDA completed an inspection of The American National Red Cross Diagnostic Manufacturing Division on February 13, 2024 in Gaithersburg, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 13, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Gaithersburg, MD (United States)